Tepsivo Pricing

First fully transparent pharmacovigilance provider with fixed monthly rates

From the old

Status-quo

Back in our early days in 2020, we expressed our distaste for the prevailing business model of the industry: hourly or unit charges.

Why? They directly incentivize inefficiencies on the side of providers. As a result, such pricing mechanics lead to ever-inflating PV budgets.

To the new

Fixed & Predictable

Since then (with 50+ clients onboard), we drive the change: Our tech-enabled business model brings true scalability & allows modern pricing principles.

Through the right use of technology, we can fully guarantee standardized, fixed recurring costs to every customer.

Here we should also highlight we never had to charge any “ad hoc” hours over the years, no “project manager” fees etc.

But this gets us back to our main point – we find such practices fully avoidable using a modern pharmacovigilance system setup.

Curious about ballpark rates?

Post-marketing pharmacovigilance

Full PV System (for authorized medicines)

Tepsivo OnePV

Complete outsourcing of all PV responsibilities in the EU/UK/US and any of 150+ markets.

Offer includes:

– Tepsivo in-house developed software covering most activities through automation & AI

– Tepsivo expert PV team to ensure scientific oversight and customer support

Tepsivo OnePV services scheme (post-marketing matrix)

Small organization
1 to 10 markets | smaller PV activity

€60K – €100K / year

Smaller to mid-size
20+ markets (eg. all of EU) | < 10K AEs annually

€200K – €350K / year

Big pharma
40+ markets | > 10K AEs annually

€500K+ / year

While we aim for maximal transparency possible, please keep in mind that numbers we share on this page are still example rates – final quote will slightly vary depending on market coverage and overall size of the client organization.

How does this compare?

~30%

of market rate

By nature this is speculative, but based on our best knowledge of the market (and thanks to insights during transitions from older PV providers), we estimate we can save around 70% in costs, especially for larger organizations.

Of course, this is something you can as well compare yourself.

Individual PV Services

We understand you may also need to outsource only selected pharmacovigilance responsibilities.

Even in such case, you still benefit from modern design of our processes and competitive rates.

Tepsivo LCPPV
Local Contact Person for PV | Any of 150+ markets

€600 / month per country

Tepsivo Literature
Highly automated medical literature monitoring | Any of 150+ markets

€100 / month per country
(local literature screening)

€1K – €5K / month
(global literature screening)

Tepsivo PV Software
Automation tools for internal client use | Rates highly vary, get in touch!

€60K – €300K / year

Clinical pharmacovigilance

(Clinical trials variant)

Tepsivo OnePV

Complete outsourcing of all PV responsibilities during clinical studies.

Includes Tepsivo in-house developed software and Tepsivo PV experts oversight & support.

Prices depend mainly on study sizes.

1 clinical trial study
Full service BPO offer.

€30K – €60K / year

For sponsors / MAHs

Bespoke offers available if post-marketing pharmacovigilance service is also included.

For CROs

Additional bespoke offers available based on total number of studies.

A quote in 24 hours

We are an open, transparent provider taking pride in our pricing. Just reach out, share any relevant info you may have, and we’ll come back to you right away.

We won’t insist on any lengthy NDA proceedings and
if you want to have a proposal, you’ll have it within a day.

Thanks to our standardized flat rates, we can easily commit to the offer.

Main price-driving factors: number of markets, size of your organization and PV operations. Total number of AE reports is helpful.

Time to send an enquiry!

Whatever your needs are, we look forward to getting in touch with you.
Feel free to drop us a message and we will contact you right away.

Book a 15-minute consultation for FREE

Drop a message